Navigation Links
AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
Date:10/16/2007

r proteins to prevent the formation of new blood vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors, allowing tumors to grow and metastasize. Dr. Benezra demonstrated that the absence of the Id genes in animals results in a highly significant inhibition of tumor growth and a reduction in the size of mature tumors. The research of Dr. Benezra on the role of the Id genes in tumor formation has been widely recognized for its important therapeutic implications.

This press release may contain forward-looking statements that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks or uncertainties related to the ability of AngioGenex to raise subsequent, substantial additional financing, to complete clinical development of AngioGenex products, and the ability of the Company to successfully develop and market AngioGenex products and technologies. These statements represent the judgment of management as of this date and are subject to risks and uncertainties that could materially affect the Company. AngioGenex undertakes no obligation to publicly release the results of any revisions to such forward-looking statements that may be made to reflect recent events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE AngioGenex Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
5. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
6. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
7. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
10. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Ever wonder what something looks like up ... of the Personal Scanning Electron Microscope (PSEM), kicked off ... send in samples to be scanned by one of ... scan range of 100nm to 5mm and an imaging ... into focus. In addition, ASPEX will not only scan ...
(Date:12/15/2009)... A Harvard medical expert internationally recognized as ... PGA Tour,s decision last month to suspend Doug ... him as having the medical condition hypogonadism ... is "unreasonable, unfair and discriminatory." ,, Hypogonadism ... testosterone levels, often referred to informally as ...
(Date:12/15/2009)... healthcare providers who have already immunized patients most ... virus may now offer the vaccine to anyone ... today. ,, Pennsylvania is expanding the H1N1 ... doses of vaccine have been allocated to healthcare ... priority groups. ,, "Many certified providers have already ...
Breaking Medicine Technology:ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 1Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 2Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 3Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 1Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 2Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 3Harden Healthcare Expands Relationship with Sandata Technologies 49734 1Harden Healthcare Expands Relationship with Sandata Technologies 49734 2
... SEATTLE, Dec. 6 Results from RESTORE 2, a,placebo-controlled, ... reduced the number of seizures in adult,patients with refractory ... dose,was added to a patient,s current anti-epileptic drug (AED) ... were experiencing,seizures despite taking stable doses of up to ...
... ASH Annual Meeting- , , ... results of a randomized phase III study presented at ... Hematology. The study in adult patients with hematological malignancies ... (TLS) demonstrated that Elitek(R) (rasburicase) significantly reduced plasma uric ...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5
(Date:12/15/2009)... Dec. 15 Palo Alto Networks(TM), the ... has deployed its PA-4000 Series next-generation firewalls for ... for enhanced visibility and control over applications such ... a Japanese national university with eight facilities on ... by integrating a number of academic schools and ...
(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...
(Date:12/15/2009)... delivered ,, WASHINGTON, Dec. 15 ... that healthcare reform does not override the prostate ... in 37 states. ,, Prostate cancer screening is ... and individuals who are identifiable as high risk, ... a family history of prostate cancer. The American ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
(Date:12/15/2009)... reduce depression and fatigue in people struggling with chronic ... from an individual,s sense of mastery over or ... certain physical goals. , The study appears in the ... arguments on fatigue being a symptom of depression," said ... at the University of Illinois and lead author of ...
Breaking Medicine News(10 mins):Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Mastery of physical goals lessens disease-related depression and fatigue 2
... Now there,s a newsletter for,people who will ... to stay,healthy, happy, and solvent as long as ... be published quarterly, debuts November 1. By promoting,healthy ... to extend,the vital years while protecting financial assets ...
... anti- inflammatory drug) treatment that can be applied directly to site of ... osteoarthritis pain * Voltaren Gel is ... and the joints ... of the hands * Offers highly effective pain relief with minimal ...
... Children of Madagascar a Healthier Future, WASHINGTON, ... with international partners, is launching a,national health campaign ... and distribute more than 1.5 million insecticide-treated,mosquito nets ... the,lives of more than 1 million African children ...
... experts say , , SUNDAY, Oct. 21 (HealthDay News) -- Some ... treat for both children and adults, according to experts at ... , "We can keep Halloween safe for everyone by taking ... vice president, said in a prepared statement. "Our vision can ...
... LAKE ZURICH, Ill., Oct. 20 Fenwal, Inc. ... to develop, distribute and,license a data capture and ... This collaboration will allow blood centers,to export data ... Manager(TM) system that will generate standard and customized,reports ...
... Oct. 19 Local youth teamed up with doctors,teachers, ... Diego,County Alcohol Policy Panel,s annual Legislative Forum on Underage ... spirits and to,investigate the labeling practices of alcoholic products ... and teachers energy drinks, some,with alcohol some without, to ...
Other Medicine News:Health News:Long Term Care Newsletter Debuts, Published by LTC Financial Partners; Advice on Living Better, Not Just Longer, With Financial Protection 2Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 2Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 3Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 4Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 5Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 6Health News:Government of Madagascar and Coalition of Global Partners Launch Measles and Malaria Prevention Campaign 2Health News:Government of Madagascar and Coalition of Global Partners Launch Measles and Malaria Prevention Campaign 3Health News:Eye on Safety Makes Halloween Less Scary 2Health News:Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc. 2Health News:Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 2
... all able to be used with the ... the RT system. , ,The VERSAPORT™ ... used with the bladed trocar systems packaged ... trocars include: VERSAPORT™ Plus RPF, VERSAPORT™ Plus ...
The SURGINEEDLE™ is a veress type needle that is used to insufflate the abdomen to create pneumoperitoneum....
... Access ...unlike any trocar system you've ever ... actually four systems in one designed ... adaptive to all of your needs., ... or dilating tip styles, OnePort™ can effectively ...
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
Medicine Products: